Abiopharma

Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results

Merck to Participate in the Jefferies Global Healthcare Conference in London

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates

DarioHealth Reports Third Quarter 2025 Financial and Operating Results

Henry Schein to Participate in Upcoming Investor Conference in December

Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases

Day One Biopharmaceuticals to Acquire Mersana Therapeutics